CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era. (9th February 2018)

Record Type:: Journal Article
Title:: CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era. (9th February 2018)
Main Title:: CD19-specific chimeric antigen receptor-modified (CAR)-T cell therapy for the treatment of chronic lymphocytic leukemia in the ibrutinib era
Authors:: Hay, Kevin A.
Turtle, Cameron J.
Abstract:
Is Part Of:: Immunotherapy. Volume 10:Number 4(2018)
Journal:: Immunotherapy
Issue:: Volume 10:Number 4(2018)
Issue Display:: Volume 10, Issue 4 (2018)
Year:: 2018
Volume:: 10
Issue:: 4
Issue Sort Value:: 2018-0010-0004-0000
Page Start:: 251
Page End:: 254
Publication Date:: 2018-02-09
Subjects:: CAR-T -- chimeric antigen receptor -- chronic lymphocytic leukemia -- cytokine-release syndrome
Immunotherapy -- Periodicals
615.37
Journal URLs:: http://www.futuremedicine.com/loi/imt?cookieSet=1 ↗
http://www.futuremedicine.com/ ↗
DOI:: 10.2217/imt-2017-0162 ↗
Languages:: English
ISSNs:: 1750-743X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4369.761480
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 22419.xml